Your browser doesn't support javascript.
loading
Predictive markers for clinical outcomes in a cohort of diabetic patients hospitalized for COVID-19.
Madaschi, Sara; Resmini, Eugenia; Bonfadini, Silvia; Massari, Giulia; Gamba, Paola; Sandri, Marco; Calza, Stefano; Cimino, Elena; Zarra, Emanuela; Dotti, Silvia; Mascadri, Cristina; Agosti, Barbara; Garrafa, Emirena; Girelli, Angela.
Afiliação
  • Madaschi S; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Resmini E; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy. resminieugenia@gmail.com.
  • Bonfadini S; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Massari G; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Gamba P; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Sandri M; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Calza S; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
  • Cimino E; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Zarra E; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Dotti S; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Mascadri C; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Agosti B; UOC Medicina Generale ad indirizzo Metabolico e Diabetologico, ASST degli Spedali Civili di Brescia, Brescia, Italy.
  • Garrafa E; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy. emirena.garrafa@unibs.it.
  • Girelli A; ASST Spedali Civili di Brescia, Department of Laboratory,, Brescia, Italy. emirena.garrafa@unibs.it.
Diabetol Metab Syndr ; 14(1): 168, 2022 Nov 12.
Article em En | MEDLINE | ID: mdl-36371199
ABSTRACT

INTRODUCTION:

The role of glycemic control, both prior and during hospitalization, on mortality from COVID-19 in diabetic patients is debated. Furthermore, it is not clear whether hyperglycemia has a direct effect or requires inflammatory mechanisms.

OBJECTIVE:

To identify predictors of clinical outcomes (in-hospital mortality, length of hospitalization, respiratory failure, need for intensive care), considering hyperglycemia, inflammation markers and clinical history.

METHODS:

Retrospective observational study of 291 diabetic patients hospitalized with COVID-19 in the Spedali Civili di Brescia from February 1th 2020 to March 31th 2021, with also outpatient electronic records. Glucose, inflammatory parameters, creatinine were collected within 24 h after admission to the hospital. A causal mediation analysis allowed the estimation of the direct and indirect effects of hyperglycemia on mortality.

RESULTS:

Glucose at admission ≥ 165 mg/dL and reduced renal function were associated with an increased risk of in-hospital mortality and length of hospitalization (all p < 0.001), while an increase in inflammatory parameters was significantly associated with an increased risk of all outcomes. High basophil count was associated with reduced mortality (p < 0.001). Hyperglycemia had a direct effect on mortality (p < 0.001); the indirect, through inflammatory markers, was significant only for absolute neutrophil count, C-Reactive protein and procalcitonin (p = 0.007, p = 0.029, p = 0.042). Patients with microvascular complications and with chronic kidney disease showed higher mortality (p = 0.03, p = 0.01).

CONCLUSIONS:

Hyperglycemia at admission, renal function and inflammatory parameters were found to be predictors of in-hospital mortality, while an increased basophil count was protective. Hyperglycemia had a direct effect on mortality, the indirect effect was only through few markers and markedly lower than the direct one.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetol Metab Syndr Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Diabetol Metab Syndr Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália